Australia markets open in 8 hours 55 minutes

Entera Bio Ltd. (ENTX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.9700-0.1000 (-4.83%)
As of 10:51AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 73.45M
Enterprise value 62.82M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)107.25
Price/book (mrq)7.07
Enterprise value/revenue 3.21k
Enterprise value/EBITDA -7.11

Trading information

Stock price history

Beta (5Y monthly) 1.71
52-week change 3172.37%
S&P500 52-week change 322.64%
52-week high 33.3500
52-week low 30.5200
50-day moving average 31.6339
200-day moving average 30.9574

Share statistics

Avg vol (3-month) 3230.36k
Avg vol (10-day) 3499.85k
Shares outstanding 535.48M
Implied shares outstanding 635.48M
Float 824.89M
% held by insiders 120.07%
% held by institutions 110.47%
Shares short (15 Apr 2024) 489.94k
Short ratio (15 Apr 2024) 40.21
Short % of float (15 Apr 2024) 40.29%
Short % of shares outstanding (15 Apr 2024) 40.25%
Shares short (prior month 15 Mar 2024) 48.09k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-44.65%
Return on equity (ttm)-80.30%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -8.84M
Net income avi to common (ttm)-8.89M
Diluted EPS (ttm)-0.3100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)11.02M
Total cash per share (mrq)0.31
Total debt (mrq)390k
Total debt/equity (mrq)3.76%
Current ratio (mrq)10.32
Book value per share (mrq)0.29

Cash flow statement

Operating cash flow (ttm)-7.31M
Levered free cash flow (ttm)-3.82M